Investor Stock List
Ranked #512 of 8,699 institutional investors

RTW Investments, LP

New York, NY

$9.50B
US stock portfolio at live prices · today −$120.8M (−1.26%)
Live prices, last trade 11:42 AM ET
Value at quarter end (Q3 2026)
$9.92B
Change from Q2 2026
−$1.79B (−15.29%)
Positions
77 · 12 new, 9 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$714M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
CGON 7.36%ARGX 7.04%PTGX 6.53%INSM 4.74%SYRE 3.70%
StockSharesValue, live% of portfoliovs Q2 2026
CGON CG Oncology, Inc.8,514,590$699M7.36%Unchanged
ARGX argenx SE711,584$669M7.04%Added +0%
PTGX Protagonist Therapeutics, Inc.5,061,175$620M6.53%Unchanged
INSM Insmed Incorporated3,096,545$450M4.74%Reduced −36%
SYRE Spyre Therapeutics, Inc.3,691,791$352M3.70%Reduced −13%
RDNT RadNet, Inc.4,630,697$326M3.44%Reduced −4%
ERAS Erasca, Inc.22,446,754$315M3.32%Added +25%
TNGX Tango Therapeutics, Inc.14,048,477$314M3.30%Added +1%
ORKA Oruka Therapeutics, Inc.3,139,030$297M3.13%Unchanged
IRTC iRhythm Holdings, Inc.3,118,913$297M3.13%Added +43%
TARS Tarsus Pharmaceuticals, Inc.3,484,066$262M2.75%Added +4%
XNCR Xencor, Inc.6,827,461$231M2.43%Added +1%
RGEN Repligen Corporation1,385,398$230M2.42%Added +12%
ZLAB Zai Lab Limited10,350,973$215M2.26%Added +57%
GH Guardant Health, Inc.1,481,033$214M2.25%Unchanged
CELC Celcuity Inc.3,304,903$181M1.90%Unchanged
NTRA Natera, Inc.600,000$166M1.75%Reduced −40%
REPL Replimune Group, Inc.8,491,525$162M1.71%Added +15%
STOK Stoke Therapeutics, Inc.5,623,525$154M1.62%Unchanged
VRDN Viridian Therapeutics, Inc.4,910,126$151M1.59%New
CYTK Cytokinetics, Incorporated2,862,003$149M1.56%Unchanged
KOD Kodiak Sciences Inc.1,487,934$147M1.55%Unchanged
NBIX Neurocrine Biosciences, Inc.942,684$145M1.52%Reduced −26%
RARE Ultragenyx Pharmaceutical Inc.8,529,394$142M1.50%Added +9%
IMCR Immunocore Holdings plc4,869,798$130M1.37%Unchanged
ACAD Acadia Pharmaceuticals Inc.7,144,524$126M1.33%Unchanged
KLRA Kailera Therapeutics, Inc.10,776,820$125M1.31%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.312,817$122M1.29%Reduced −84%
IMVT Immunovant, Inc.3,177,849$102M1.08%Unchanged
BLTE Belite Bio, Inc715,332$93.5M0.98%Unchanged
PTCT PTC Therapeutics, Inc.1,615,819$93.4M0.98%Reduced −79%
AXGN Axogen, Inc.1,659,376$92.3M0.97%Added +64%
CSTL Castle Biosciences, Inc.2,778,335$91.2M0.96%Unchanged
CMPS COMPASS Pathways plc10,948,591$88.9M0.94%Added +2%
OBIO Orchestra BioMed Holdings, Inc.9,556,063$64.3M0.68%Unchanged
COGT Cogent Biosciences, Inc.2,309,021$62.8M0.66%Unchanged
HNGE Hinge Health, Inc.500,000$53.5M0.56%Unchanged
DHR Danaher Corporation230,000$51.5M0.54%Unchanged
TSHA Taysha Gene Therapies, Inc.13,560,258$50.7M0.53%Unchanged
VSTM Verastem, Inc.6,718,081$44.8M0.47%Added +1%
GPCR Structure Therapeutics Inc.2,282,138$37.4M0.39%Added +42%
SLDB Solid Biosciences Inc.5,905,426$37.1M0.39%Added +52%
RCKT Rocket Pharmaceuticals, Inc.17,687,772$36.0M0.38%Unchanged
NGNE Neurogene Inc.1,512,456$34.3M0.36%Added +11%
KRSA Korsana Biosciences, Inc.877,020$32.1M0.34%New
KYMR Kymera Therapeutics, Inc.240,000$27.9M0.29%Unchanged
AQST Aquestive Therapeutics, Inc.7,426,471$26.1M0.28%Unchanged
AKTS Aktis Oncology, Inc.1,592,043$26.1M0.27%Unchanged
SVRA Savara Inc.5,952,380$25.3M0.27%Unchanged
CGEM Cullinan Therapeutics, Inc.2,364,347$21.4M0.22%Unchanged
DNTH Dianthus Therapeutics, Inc.248,063$20.9M0.22%Unchanged
LRMR Larimar Therapeutics, Inc.5,820,891$17.5M0.18%Added +127%
CADL Candel Therapeutics, Inc.3,211,008$16.5M0.17%Reduced −50%
SLN Silence Therapeutics plc700,000$13.9M0.15%New
BBNX Beta Bionics, Inc.998,855$13.5M0.14%Reduced −33%
BEAM Beam Therapeutics Inc.570,394$12.2M0.13%Unchanged
PYXS Pyxis Oncology, Inc.6,506,229$11.8M0.12%New
SRZN Surrozen, Inc.393,560$11.6M0.12%New
HTFL Heartflow, Inc.250,000$11.5M0.12%Reduced −15%
IPSC Century Therapeutics, Inc.8,695,652$10.6M0.11%Unchanged
LTGO Latigo Biotherapeutics, Inc.700,000$9.1M<0.1%New
LMRI Lumexa Imaging Holdings, Inc.500,000$7.1M<0.1%Reduced −23%
FRNM Freenome, Inc.742,500$7.0M<0.1%New
OCGN Ocugen, Inc.6,666,666$5.3M<0.1%Unchanged
DYN Dyne Therapeutics, Inc.300,000$4.8M<0.1%New
ADRX ADARx Pharmaceuticals, Inc.300,000$4.1M<0.1%New
RGNX REGENXBIO Inc.555,555$3.9M<0.1%New
MIST Milestone Pharmaceuticals Inc.7,833,336$3.0M<0.1%Unchanged
MDLN Medline Inc.70,000$2.6M<0.1%Unchanged
IRON Disc Medicine, Inc.30,000$2.2M<0.1%Unchanged
ALLO Allogene Therapeutics, Inc.3,250,000$2.1M<0.1%Unchanged
CAPR Capricor Therapeutics, Inc.250,000$2.0M<0.1%Unchanged
ABVX ABIVAX Société Anonyme26,400$1.9M<0.1%Unchanged
KLRS Kalaris Therapeutics, Inc.1,300,000$1.7M<0.1%Unchanged
EVMN Evommune Inc208,071$1.5M<0.1%Reduced −86%
OBX Obsidian Therapeutics, Inc.67,706$810K<0.1%New
LXEO Lexeo Therapeutics, Inc.239,149$764K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
DFTX Definium Therapeutics, Inc.400,000$11.7M
IDYA IDEAYA Biosciences, Inc.370,370$9.6M
MAZE Maze Therapeutics, Inc.212,000$6.8M
FDMT 4D Molecular Therapeutics, Inc.475,737$5.0M
WVE Wave Life Sciences, Inc.1,350,000$3.6M
IMA ImageneBio, Inc.334,445$1.3M
AVTX Avalo Therapeutics, Inc.175,000$1.2M
TENX Tenax Therapeutics, Inc.696,570$885K
XGN Exagen Inc.195,000$724K